RÉSUMÉ DIGEST
ACT 82 (HB 192) 2017 Regular Session Moreno
New law prohibits a medical practitioner from prescribing more than a seven-day supply
when issuing a first time opioid prescription for outpatient use to an adult patient with an
acute condition.
New law prohibits a medical practitioner from issuing a prescription for more than a
seven-day supply of an opioid to a minor at any time and requires the practitioner to discuss
with a parent, tutor, or guardian of the minor the risks associated with opioid use and the
reasons why the prescription is necessary.
New law exempts prescriptions for more than a seven-day supply which, in the professional
medical judgment of the medical practitioner, are necessary to treat the adult or minor
patient's acute medical condition or are necessary for the treatment of chronic pain
management, pain associated with a cancer diagnosis, or for palliative care.
New law requires a medical practitioner to do both of the following prior to issuing a
prescription for an opioid:
(1)Consult with the patient regarding the quantity of the opioid and the patient's option
to fill the prescription in a lesser quantity.
(2)Inform the patient of the risks associated with the opioid prescribed.
New law authorizes a pharmacist filling a prescription for an opioid to dispense the
prescribed substance in an amount less than the recommended full quantity indicated on the
prescription if requested by the patient. Further authorizes the patient to request that the
pharmacist fill an additional amount not to exceed the remaining prescribed quantity in
accordance with federal law provisions regarding prescriptions for controlled dangerous
substances.
New law requires, if the dispensed amount is less than the recommended full quantity, the
pharmacist or a designee to ensure that the actual dispensed amount is accurately recorded
in the prescription monitoring program. Further requires the pharmacist or a designee to
also, within seven days, make a notation in the interoperable electronic health record of the
patient if the pharmacist has access to the record.
Effective August 1, 2017.
(Adds R.S. 40:978(G) and (H))